Lindsey Herrel, MD, MS
Urology
2800 Plymouth Rd, Bldg 16, Rm 109E
Ann Arbor, MI 48109-2800
Manage Your Profile
About
Lindsey Herrel MD, MS is a practicing urologic oncologist at the University of Michigan. She is a graduate of the Saint Louis University School of Medicine and completed her residency in urology at Emory University. She received a Master’s of Science in Health and Health Care Research at the University of Michigan where she completed a fellowship in Urologic Oncology and Health Services Research. Her clinical interests focus on the care of patients with urologic malignancies, including cancers of the kidney, testis, prostate, bladder, adrenal gland and penis. Her primary areas of research interest focus in health policy and include understanding the impact of payment reform for safety net hospitals and vulnerable populations.
Qualifications
-
FellowshipUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2014 - 2017
Clinical Fellowship
-
ResidencyEmory University, Atlanta, United States
2009 - 2014
Residency
Center Memberships
-
Center MemberCenter for Global Health Equity
-
Center MemberRogel Cancer Center
-
Center MemberInstitute for Healthcare Policy and Innovation
Research Overview
Dr. Herrel’s research focuses on population-based analyses to assess and anticipate the impact of healthcare reform on safety net hospitals and vulnerable or underserved populations. She also has research interests in understanding how organizational structure within a health system (e.g. Accountable Care Organizations) impacts delivery of care.
Recent Publications
-
Krischak M, Bank M, Daignault-Newton S, Semerjian, MD A, Sekar R, Sbei B, Piatt G, Landis-Lewis Z, Barnes G, Lewicki P, Morgan T, Caram M, Sales A, Skolarus T, Herrel L, Stensland K. Urologic Oncology: Seminars and Original Investigations, 2025 Jul 21;Journal ArticleAssessing the sex-based enrollment gap in urologic oncology clinical trials
-
Merrill NM, Kaffenberger SD, Bao L, Vandecan N, Goo LE, Apfel A, Cheng X, Qin Z, Liu C-J, Bankhead A, Wang Y, Kathawate V, Tudrick L, Serhan H, Farah Z, Ellimoottil CS, Hafez KS, Herrel LA, Montgomery JS, Morgan TM, Salami SS, Weizer AZ, Ulintz PJ, Day ML, Soellner MB, Palmbos PL, Merajver SD, Udager AM. Clinical Cancer Research, 2025 Mar 26; 30 (10_Supplement): A009 - A009.Proceeding / Abstract / PosterIntegrative drug screening and multi-omic characterization of patient-derived bladder cancer organoids reveals novel molecular correlates of chemotherapy response
DOI:10.1158/1557-3265.bladder24-a009 -
Kaffenberger SD, Brown J, Merrill N, Marchetti K, Bao LW, Cheng X, Udager AM, Herrel LA, Vandecan N, Montgomery JS, Hafez K, Weizer A, Morgan TM, Alva AS, Soellner M, Merajver S. JOURNAL OF CLINICAL ONCOLOGY, 2025 Jul 31; 38 (6):Proceeding / Abstract / PosterRapid organoid development, drug screening, and neoadjuvant chemotherapy response prediction for patients with locally advanced bladder cancer
-
Borza T, Oerline MK, Skolarus TA, Norton EC, Dimick JB, Jacobs BL, Herrel LA, Ellimoottil C, Hollingsworth JM, Ryan AM, Miller DC, Shahinian VB, Hollenbeck BK. Annals of Surgery, 2025 May 13; 269 (5): 873 - 878.Journal ArticleAssociation between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery
DOI:10.1097/SLA.0000000000002737 -
Lee M, Cole A, Johnson A, Qi J, Linsell S, Martin R, Ellimoottil C, Herrel L, Wei JT, Salami S, Curci N, Davenport M, Shankar P, Miller DC, Montie J, George AK. Journal of Urology, 2025 Jul 10; 201 (Supplement 4):Proceeding / Abstract / PosterProspective Evaluation of Novel Transperineal Electromagnetically-Tracked MR/US Fusion Biopsy System
DOI:10.1097/01.ju.0000555523.18763.e5
Featured News & Stories
